Janux Therapeutics (JANX) Interest Coverage Ratio (2020)

Janux Therapeutics (JANX) reported Interest Coverage Ratio of 10.15 for Q2 2020.

Janux Therapeutics (JANX) Interest Coverage Ratio (2020) Analysis & Trends

Janux Therapeutics (JANX) has 1 years of Interest Coverage Ratio data on file, last reported at 10.15 in Q2 2020.

Interest Coverage Ratio for Q2 2020 came in at 10.15, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was 57.81 (changed N/A YoY), and the FY2020 annual result was 23.51, changed N/A from the prior year.
Interest Coverage Ratio steadied at 10.15 in Q2 2020 per JANX's latest filing.
Over five years, Interest Coverage Ratio peaked at 10.15 in Q2 2020 and troughed at 10.15 in Q2 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	3.58
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	11.50
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-258.33
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	547.67
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	11.79
10	Janux Therapeutics	892.99 Mn	892.99 Mn	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2020	-10.15